Champions Oncology, Inc.
CSBR
Rank in Stocks
#21456
Champions Oncology, Inc. is dedicated to developing and commercializing... Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice. Utilizing this proprietary platform, the company not only delivers personalized cancer solutions directly but also provides Translational Oncology Solutions, supporting pharmaceutical and biotechnology companies through their drug development lifecycle. Additionally, Champions Oncology offers Lumin Bioinformatics, a comprehensive software platform and data tool filled with insights from research services and clinical studies, accessible through annual subscriptions. The company distributes its offerings through various channels, including online platforms, word-of-mouth referrals, and a dedicated sales team, reaching both patients and healthcare professionals. Established in 1985, Champions Oncology, Inc. is based in Hackensack, New Jersey, and was formerly known as Champions Biotechnology, Inc. until its name change in April 2011.
Share Price
$4.84
Last synced: 2026-11-09
Market Cap
$67.37M
Change (1 day)
1.04%
Change (1 year)
-30.86%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Champions Oncology, Inc. (CSBR)
Category
Healthcare
Operating Margin for Champions Oncology, Inc. (CSBR)
Operating Margin as of November 2026 TTM: -1.72%
According to Champions Oncology, Inc.'s latest financial reports, its current operating margin (TTM) is -1.72%. At the end of 2025 the company had an operating margin of 8.51%.
Operating Margin history for Champions Oncology, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1.72% | -120.21% |
| 2025 | 8.51% | -161.67% |
| 2024 | -13.80% | 67.07% |
| 2023 | -8.26% | -766.13% |
| 2022 | 1.24% | 39.33% |
| 2021 | 0.89% | -118.02% |
| 2020 | -4.94% | -594.00% |
| 2019 | 1.00% | -114.95% |
| 2018 | -6.69% | -84.86% |
| 2017 | -44.18% | -52.11% |
| 2016 | -92.26% | -38.23% |
| 2015 | -149.36% | 175.57% |
| 2014 | -54.20% | -27.48% |
| 2013 | -74.74% | -41.06% |
| 2012 | -126.80% | 66.69% |
| 2011 | -76.07% | 27.12% |
| 2010 | -59.84% | -4.71% |
| 2009 | -62.80% | 99.81% |
| 2008 | -31.43% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | -5.87% | 8.91% |
| 2004 | -5.39% | -25.96% |
| 2003 | -7.28% | 5.20% |
| 2002 | -6.92% | -67.39% |
| 2001 | -21.22% | -3,175.36% |
| 2000 | 0.69% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -122.44% |
US
|
|
| -149.01% | -13.37% |
US
|
|
| 25.57% | -114.87% |
AU
|
|
| 31.23% | -118.16% |
BE
|
|
| 29.35% | -117.06% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Champions Oncology, Inc.'s operating margin
What is Champions Oncology, Inc.'s operating margin?
Champions Oncology, Inc.'s operating margin is -1.72%, as of Nov 2026.
What was Champions Oncology, Inc.'s operating margin in 2025?
In 2025, Champions Oncology, Inc.'s operating margin was 8.51%, compared with -13.80% in 2024.
How has Champions Oncology, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Champions Oncology, Inc.'s operating margin was highest in 2025 (8.51%) and lowest in 2024 (-13.80%).
How does Champions Oncology, Inc.'s operating margin compare with similar companies?
Champions Oncology, Inc.'s operating margin (-1.72%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.